- $3.61bn
- $11.03bn
- $6.22bn
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT
Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln
Brief: Organon Announces Agreement to Divest its JADA System for Up to $465 Million to Laborie
U.S. STOCKS ON THE MOVE-PepGen, Turbo Energy, Qualcomm
Brief: Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation
Organon falls as CEO resigns after probe into contraceptive sales
Organon CEO Kevin Ali to resign after probe into contraceptive sales (updated)
Organon CEO Kevin Ali to resign after probe into wholesaler sales practices
Organon & Co reports results for the quarter ended June 30 - Earnings Summary
Organon beats Q2 revenue expectations, raises FY guidance
U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial
U.S. STOCKS ON THE MOVE-Tesla, ABM Industries, Regeneron
U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier
Organon falls on halting development of endometriosis pain drug
Organon to halt development of endometriosis pain drug after mid-stage trial failure (updated)
Organon to halt development of pelvic pain drug after mid-stage trial failure
Brief: Organon Provides Update On Phase 2 Elena Proof-Of-Concept Study Evaluating OG-6219 In Patients With Endometriosis-Related Pain
Brief: EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets
EU drugs regulator confirms suicidal thoughts as side effect of hair loss drug (updated)